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Abstract Preterm infants are very susceptible to infec-
tions. Immune response mechanisms in this group of
patients and factors that influence cord blood mononuclear
cell populations remain poorly understood and are con-
sidered insufficient. However, competent immune
functions of the cord blood mononuclear cells are also
described. The aim of this work was to evaluate the T-cell
population (CD3?) with its subpopulations bearing T-cell
receptor (TCR) ab or TCR cd in the cord blood of preterm
infants born before 32 weeks of gestation by mothers with
or without an intrauterine infection. Being a pilot study, it
also aimed at feasibility check and assessment of an
expected effect size. The cord blood samples of 46 infants
age were subjected to direct immunofluorescent staining
with monoclonal antibodies and then analyzed by flow
cytometry. The percentage of CD3? cells in neonates born
by mothers with diagnosis of intrauterine infection was
significantly lower than in neonates born by mothers
without infection (p = 0.005; Mann–Whitney U test). The
number of cells did not differ between groups. Infection
present in the mother did not have an influence on the TCR
ab or TCR cd subpopulations. Our study contributes to a
better understanding of preterm infants’ immune mecha-
nisms, and sets the stage for further investigations.
Keywords CD3? cells  Gamma/delta T cells 
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Introduction
Preterm infants, especially those born before 32nd week of
gestation, are at a high risk of developing life-threatening
conditions, such as a respiratory distress or sepsis (Max-
well et al. 2006; Stoll et al. 2005). One of the main causes
of perinatal morbidity and mortality of these patients is the
intrauterine infection of bacterial etiology proven to be
responsible for preterm delivery (Goldenberg et al. 2008;
Romero et al. 2007; Stoll et al. 2005). Neonates born by
mothers with histopathologic diagnosis of chorioamnionitis
are more likely to suffer from such long-term complica-
tions as periventricular leukomalacia and cerebral palsy
(Duggan et al. 2001). Immune response mechanisms in
neonates, especially in preterms, are not well established
and they are considered very premature and insufficient to
fight infections (Marodi 2006; Schelonka and Infante
1998). However, even during the fetal period immune
response to mother’s infection is observed (Zhao et al.
2002), and cord blood mononuclear cells are known to
secrete significant amounts of proinflammatory cytokines
(Cairo et al. 2008; Chipeta et al. 2000; Koehler et al. 2008).
Yet the development of the human immune system during
the prenatal and perinatal period is not precisely under-
stood. Factors that have an influence on different immune
cell populations remain unclear.
In this work, which is a pilot study for further research,
the T-cell population and its subpopulations expressing
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T-cell receptor (TCR) ab and cd were studied in very
preterm infants, born before 32 weeks gestational age. T
cells are a part of acquired immunity and would rather
seem to play a minor role in newborn immune responses.
However, their subpopulation bearing the cd TCR is con-
sidered as the first line of defense in bacterial infections
(Follows et al. 1992; Jouen-Beades et al. 1997; Konig-
shofer and Chien 2006; Moore et al. 2000; Nakasone et al.
2007; Xiong and Raulet 2007). There are studies on human
neonates, in which cd T cells were found highly reactive to
pathogens compared to the subpopulation ab. Other studies
describe higher percentage of memory cells among the cd
subpopulation in cord blood than in other subpopulations of
cells (De Rosa et al. 2004; Gibbons et al. 2009). As the
preterm birth is frequently related to bacterial intrauterine
infection (Goldenberg et al. 2008; Romero et al. 2007;
Sherman et al. 1997), the present study was done to eval-
uate the effect of this kind of infection on T-cell population
(CD3? cells, with subsets ab and cd) in newborns. We
hypothesized, based on the above findings, that the pres-
ence of bacterial infection in the mother during delivery
would increase the number and/or percentage of cd T cells
in cord blood of preterm newborn.
Materials and Methods
The study material consisted of 46 newborns born before
completing 32 weeks of gestation in Princess Anna
Mazowiecka Hospital and hospitalized in the Neonatal and
Neonatal Intensive Care Department of the Medical Uni-
versity of Warsaw, during the years 2007–2009. Twenty-
nine of the newborns (group I) were children of mothers
with intrauterine infection. Within this group 14 newborns
did not develop signs of neonatal infection and 15
presented with clinical and laboratory signs of infection.
Seventeen neonates (group II) came from mothers without
infection. The main characteristics of the groups of studied
infants are presented in Table 1. Mothers with any TORCH
(toxoplasmosis; other—measles, influenza, syphilis;
rubella; cytomegalovirus; herpes)infection diagnosis, and
babies with congenital defects were excluded from the
study. Signing the informed consent by the parents was a
necessary inclusion criterion.
The study was approved by the Ethical Committee of
the Medical University of Warsaw.
The maternal infection was initially diagnosed based on
the clinical signs and/or laboratory tests (C-reactive pro-
tein: CRP, number of white blood cells: WBC). Results of
bacterial cultures of maternal vaginal smears and amniotic
fluid were acknowledged later, as well as histologic results.
In the preterm birth, intrauterine infection may manifest
with very subtle clinical signs. Therefore, any positive
laboratory findings, together with positive bacterial cul-
tures and/or histologic chorioamnionitis, were sufficient to
qualify the patient to the group with infection (Locksmith
and Duff 2001; Newton 2005; Romero et al. 2007; Snyder
et al. 2007). Intravenous antibiotic therapy is routinely
administered to most mothers during preterm labor (Bal-
timore 2007; Locksmith and Duff 2001; Snyder et al.
2007). Mothers colonized with group B streptococcus
received ampicillin, and those colonized with other species
received ampicillin plus sulbactam. In the case of allergy to
penicillins, cefuroxime or erythromycin was administered.
In group I, five mothers were considered untreated. Those
were the mothers who delivered their babies either before
receiving their first dose or right after that dose (up to
30 min), which was considered rather ineffective. In group
II, 8 of 17 mothers received the treatment. Those mothers
either had vaginal colonization with pathogenic flora or
Table 1 Main characteristics of the studied groups
Group I (n = 29) Group II (n = 17) p value* Group Ia (n = 14) Group Ib (n = 15) p value*
Gestational age (weeks)
Median (range) 29 (24–31) 30 (26–31) 0.04 29 (25–31) 28 (24–31) NS
Birthweight (g)
Median (range) 1,088 (640–1,650) 1,460 (720–1,860) 0.022 1,305 (640–1,560) 1,020 (660–1,650) NS
Sex M/F
Number (%) 15/14 (51/49 %) 8/9 (47/53 %) NS 6/8 (43/57 %) 9/6 (60/40 %) NS
Type of delivery V/C
Number (%) 15/14 (51/49 %) 3/14 (18/82 %) 0.048 5/9 (36/64 %) 10/5 (67/33 %) NS
Antibiotic treatment of the mother
Number (%) 24 (83 %) 8 (47 %) 0.027 12 (85 %) 12 (80 %) NS
M male, F female, V vaginal delivery, C caesarian section, NS not significant
* Values assess the differences between the fractions
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premature rupture of membranes, which were considered
as the infection risk factor.
Diagnosis of neonatal infection was established by
repeated blood testing for complete blood count with dif-
ferential count and CRP. Blood cultures were obtained
before administering routine antibiotic therapy (ampicillin
and netilmycin). About 48 h after birth, the neonates from
group I were assigned to groups Ia (14 neonates) and Ib (15
neonates) according to clinical and laboratory findings.
These were the groups where children did not and did
develop infection, respectively (Polin and Spitzer 2001).
The cord blood samples (about 1 cm3) were collected at
birth to the EDTA tubes and subjected to analysis. Number
of blood leukocytes was estimated on Coulter LH750
hematological analyzer (Beckman Coulter, Inc., USA) and
their concentration was adjusted to 5,000/ll either by
dilution with 0.9 % NaCl or centrifugation. Then, the
blood samples were stained with the following monoclonal
antibodies: anti-CD3 FITC clone: W31, anti-CD3 PE
clone: 11F2, anti-TCR a/b FITC clone: WT31, anti-TCR
c/d PE clone: 11F2 and FITC i PE isotype controls, all
purchased from the Diag-Med authorized distributor of BD
Biosciences (USA). A direct immunofluorescent staining
of the whole blood was performed according to BD Bio-
sciences procedures. The red cells were lysed and binding
to monoclonal antibodies was fixed with Uti-Lyse Eryth-
rocyte Lysing Reagents (Dako, USA). This procedure was
performed according to the Dako procedures. Routinely,
1 9 104 cells were analyzed by two-color flow cytometry
on Cytomix FC 500, Beckman Coulter. The percentage and
number of total T cells (CD3? cells), and then of ab
(CD3? TCR ab) and cd (CD3? TCR cd) subpopulations
were determined in the population of lymphocytes gated
on lymphocyte base FCS/SCC diagram.
Given that the normality assumption was rejected at a
baseline 0.05 significance level in majority of the results
(Shapiro–Wilk test), the independent group comparisons
were performed using a non-parametric Mann–Whitney
approach. Due to a small sample size, a continuity cor-
rection of the testing statistics was applied. The Bonferroni
correction method was used to adjust the baseline signifi-
cance level for a multiple testing bias. All the analyses and
graphics were performed using the software R version
2.15.2 (R Foundation for Statistical Computing, Vienna,
Austria).
Results
Table 1 presents the main features of studied groups of
neonates, gestational age, birthweight, type of delivery,
and the mother antibiotic therapy type. The median CRP in
mothers from group I was 33 mg/l (normal range 0–10 mg/ T
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l; 25th–75th percentile 17–67 mg/l), median of WBC was
16.2 9 10e9/l (25th–75th percentile 12.9–18.8) (normal
range 4–11 9 10e9/l). The median CRP for group II was
5 mg/l (25th–75th percentile 4–9 mg/l), and median WBC
11.6 (25th–75th percentile 10.1–15). Those values differed
significantly between groups (Mann–Whitney U test,
p \ 0.001 for CRP, p \ 0.01 for WBC). Infants of group Ia
and II had CRP B10 mg/l and WBC within normal range
for their age, while infants from group Ib had median of
CRP 17 mg/l. In addition, three of them had also positive
blood cultures.
The total WBC in the studied infants ranged from 3.5 to
45.3 9 10e9/l, and the lymphocytes from 20.6 to 88.8 % of
total leukocytes, which gave the number of lymphocytes
from 1,796 to 18,648/mm3. The numbers and percentages
of T lymphocytes (with ab and cd T cells) are presented in
detail in Table 2. The percentage of CD3? cells was sig-
nificantly lower in group I than in group II (p \ 0.01).
There was no significant difference in number of CD3?
cells between group I and II. No significant differences in
CD3? cell number or percentage were found between
uninfected and infected newborns of mothers with intra-
uterine infection (group Ia vs. Ib, p not significant) (Fig. 1).
The percentages and numbers of CD3? TCR ab and
CD3? TCR cd cells did not differ significantly between
groups I and II nor groups Ia and Ib (Figs. 2, 3).
Discussion
The present study was conducted to evaluate the associa-
tion between intrauterine infection of bacterial etiology and
the T-cell population in newborn’s cord blood. The
mechanisms of newborn immune response remain unclear,
and this is especially true for very preterm newborns. Some
previous studies on neonatal immunology suggest that fetal
and early neonatal cytokine production is biased toward
Th2 type response. Suppression of interferon (IFN)-c
secretion (the main cytokine in Th1 response) is due to a
higher expression and secretion of interleukin 4 by Th2
cells (Langrish et al. 2002; Zaghouani et al. 2009). An
increased production of pro-inflammatory cytokines such
as IFN-c may cause damage of the placenta and therefore
lead to miscarriage, preterm birth, or serious fetal injury
(Marodi 2006; Romero et al. 2007). Therefore, the Th1
response suppression seems to be an important evolution-
ary mechanism, necessary for proper pregnancy
maintenance.
Our results prove that intrauterine infection affects the
T-cell population. The percentage of CD3? cells in new-
borns born by mothers with intrauterine infection was
significantly lower than in the newborns of mothers without
infection (p = 0.005). This outcome is in line with Juretic
et al. (2001) findings, who studied lymphocyte subsets in
preterm infants too. Other authors, however, did not
describe this effect. In Kotiranta-Ainamo et al. (1999), the
percentage of CD3? cells in newborns with intrauterine
infection was higher than in uninfected newborns, and in
Matsuoka et al. (2001) the difference in CD3? lympho-
cytes between groups of infected and uninfected infants
was not significant. These discrepancies are probably due
to a small number of patients included in the studies, which
is not unusual in this type of research. Most of the cited
literature is based on the groups of patients \50 (Juretic
Fig. 1 Percentage (a) and number (b) of CD3? cells in cord blood of
studied neonates. Group I—neonates of mothers with intrauterine
infection, in this Group Ia—neonates without signs of infection,
Group Ib—neonates with diagnosed infection, Group II—neonates of
mothers without infection
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et al. 2001; Kotiranta-Ainamo et al. 1999; Matsuoka et al.
2001; Mazur et al. 2004). This probably results from
problems with obtaining cord blood sample in the most
immature neonates, who, in most cases, require resuscita-
tion at birth, engaging all the present personnel. The other
reason for these discrepancies might be different gesta-
tional age of the studied populations. The study presented
here consisted only of preterm neonates, similarly to the
study conducted by Juretic et al. (2001). The two other
studies of Kotiranta-Ainamo et al. (1999) and Matsuoka
et al. (2001) included also term infants, which might be a
matter of significance for the immunologic mechanisms.
Because of the limited number of studies and the fact that
only term newborns are usually considered, it is quite
difficult to discuss the above results. Our study is one of the
very few performed on a population of children born before
completing 32 weeks of gestation. Another problem is that
different authors evaluate different subpopulations of
Fig. 2 Percentage (a) and number (b) of CD3? TCR ab cells in cord
blood of studied neonates. Group I—neonates of mothers with
intrauterine infection, in this Group Ia—neonates without signs of
infection, Group Ib—neonates with diagnosed infection, Group II—
neonates of mothers without infection
Fig. 3 Percentage (a) and number (b) of CD3? TCR cd cells in cord
blood of studied neonates. Group I—neonates of mothers with
intrauterine infection, in this Group Ia—neonates without signs of
infection, Group Ib—neonates with diagnosed infection, Group II—
neonates of mothers without infection
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mononuclear cells, therefore, the results are not compara-
ble. Some studies assess the activation of cells measured by
cytokine concentrations (Gibbons et al. 2009; Matsuoka
et al. 2001), but they do not consider the quantity evalua-
tion of cell populations.
Because the gestational age of the studied groups dif-
fered significantly (lower gestational age in the group of
neonates born by infected mothers), as well as infants’
birthweight, our outcomes must be interpreted with cau-
tion. This fact, although it might raise doubts of statistics
credibility, is consistent with the known dependence of
intrauterine infection frequency and gestational age
(Goldenberg et al. 2008; Maxwell et al. 2006; Romero
et al. 2007). Intrauterine infection is more often present in
the most immature and therefore the smallest neonates.
The present study considers also the role of a unique
subpopulation of T cells: the CD3? TCR cd. This subset is
a subject of many studies, appearing, among other func-
tions, as the first line of defense in bacterial infections
(Follows et al. 1992; Jouen-Beades et al. 1997; Konig-
shofer and Chien 2006; Moore et al. 2000; Nakasone et al.
2007; Xiong and Raulet 2007). The reaction of the cd T
cells to bacterial antigens and their ability to secrete IFN-c
is spontaneous and independent from the major histocom-
patibility complex. This is a very unique feature among
lymphocytes, and this subpopulation is often described as a
‘‘bridge’’ between innate and acquired immunity (Beetz
et al. 2008). The cd T cells are often described as an
immature or primitive subpopulation of T cells which
develops early during ontogeny (Konigshofer and Chien
2006; Xiong and Raulet 2007), and might be a significant
part of preterm infants’ immune response. Therefore, we
found it interesting to investigate this subpopulation in
preterm infants. Their presence and increased activity in
the case of bacterial intrauterine infection might be a par-
tial explanation for the increased Th1 type response in the
otherwise Th2-biased immune system of the newborn.
There is a very limited number of studies on this subset
of cells in intrauterine infection, while most of them are
performed on term infants. Our results show no significant
differences in the CD3? TCR cd cell number or percentage
in cord blood of preterm infants of mothers with bacterial
intrauterine infection compared to newborns from unin-
fected mothers. The observation here in preterm infants
agree with the data of Mazur et al. (2004) seen in term
newborns. Data reported by Gibbons et al. (2009) show an
increased IFN-c production by the cd subset of CD3? cells
in preterm newborns. Unfortunately, these authors did not
show any quantity evaluation results of these cell subsets.
Taken together, the above results might suggest that the
role of the cd T cells in intrauterine infection is based more
on an increased cell activation measured by cytokine pro-
duction, rather than increased cell number or percentage.
However, to prove this, further studies, taking into account
both the quantity assessment and cell activation, are
required.
In conclusion, the presented results might contribute to a
better understanding of the immune response in very pre-
term infants. It sets the stage for further studies with a
greater number of patients to fully assess the mechanisms
involved in premature infants’ immunologic reactions.
Such a study is planned for the near future.
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